Large-scale testing (Phase 3)Ended earlyNCT01950455
What this trial is testing
Evaluation of the Diagnostic Efficacy and Safety of [123I]NAV5001 as an Imaging Agent to Aid in the Diagnosis of Parkinsonian Syndromes
Who this might be right for
Parkinson's Syndrome
Navidea Biopharmaceuticals 13